Brought to you by The INFO Project
Implantable Contraceptives Toolkit
Up-to-date evidence, best practices and related resources to Implantable Contraceptives
Resources for Policy Makers
|
The resources listed here can help policy makers review and update national policies and guidelines for implants and plan for future development. Topics include policy issues concerning implants and a case study of a national training program for nurses that increased the use of implants.
|
 |
- New Implants Can Expand Access
[from "Implants: The Next Generation" Population Reports issue K-7]
Description: Contraceptive implants offer women many advantages that can suit their reproductive intentions and that make continued use easy. The most important improvement that the new implants offer is easier and quicker insertion and removal. With new implants making the method easier to provide, more programs may want to begin offering implants. -
Medical Eligibility Criteria for Contraceptive Use (Third Edition)
(French) (Spanish) (Russian) (Portuguese) [World Health Organization]Description: This document reviews the medical eligibility criteria for use of contraception, offering guidance on the safety of use of 19 different methods for women and men, including implants, with specific characteristics or known medical conditions. The recommendations are based on systematic reviews of available clinical and epidemiological research and are reached by consensus among experts representing organizations working internationally on reproductive health. This document aims to support national programs in the preparation of service delivery guidelines. - Selected Practice Recommendations for Contraceptive Use (Second Edition) (French) (Spanish) [World Health Organization]
Individual Questions:
-
Description: This document provides guidance on the safe and effective use of a wide range of contraceptive methods, including implants, and is the companion guide to WHO's Medical Eligibility Criteria (MEC) for Contraceptive Use. Like the MEC, the recommendations are based on systematic reviews of available clinical and epidemiological research and are reached by consensus among experts representing organizations working internationally on reproductive health. This document aims to support national programs in the preparation of service delivery guidelines.
-
INFO Reports: WHO Updates Medical Eligibility Criteria for Contraceptives (French) (Spanish) [The INFO Project at the Johns Hopkins Bloomberg School of Public Health]Description: This issue focuses on changes and new criteria from WHO's 2004 Medical Eligibility Criteria for Contraceptive Use. Includes the recommendations for Norplant which can also be applied to Implanon.
-
INFO Reports: World Health Organization Updates Guidance on How To Use Contraceptives (French) (Spanish) [The INFO Project at the Johns Hopkins Bloomberg School of Public Health]Description: This issue focuses on the new guidance from WHO's 2004 Selected Practice Recommendations. It notes that while Norplant is usually approved for five years of use, recent evidence shows that the implants remain effective for seven years in women weighing less than 70 kg (154 pounds).
-
International Planned Parenthood Federation's Medical and Service Delivery Guidelines for Sexual and Reproductive Health Services, Implants chapter (Third Edition) (French) (Arabic) (Russian) [International Planned Parenthood Federation]Description: These guidelines are intended to improve the knowledge, skills, and confidence of service providers in the delivery of high-quality sexual and reproductive health services.
-
WHO Model List of Essential Medicines (15th edition, March 2007) (French) (Chinese) (Russian) [World Health Organization]Description: The document presents a list of minimum medicine needs for a basic health care system, listing the most effective, safe, and cost-effective medicines for priority conditions. Priority conditions are selected on the basis of current and estimated future public health relevance, and potential for safe and cost-effective treatment. This list now includes the two-rod levonorgestrel-releasing implant, with each rod containing 75 mg levonorgestrel (150 mg total).
-
Spotlight, "Training Nurses to Provide Implants Increases Use in Ghana"Description: This spotlight describes how the Ghana Ministry of Health and EngenderHealth collaborated to train a large group of nurses in implant insertion and removal and in related counseling. This effort contributed to a ten-fold increase in the number of women using implants in Ghana. [from "Implants: The Next Generation," Population Reports issue K-7
Information & Knowledge for Optimal Health (INFO) Project
111 Market Place Suite 310, Baltimore, MD 21202
Phone: 410-659-6300 Fax: 410-659-6266 Security & Privacy Policy
Disclaimer: The information provided on this web site is not official U.S. Government information and does not represent the views or positions of the U.S. Agency for International Development, the U.S. Government or The Johns Hopkins University.